These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 31383954)
1. Preoperative PI-RADS Version 2 scores helps improve accuracy of clinical nomograms for predicting pelvic lymph node metastasis at radical prostatectomy. Huang C; Song G; Wang H; Lin Z; Wang H; Ji G; Zhang S; Guo Y; Li J; Bao Z; Hong P; Du Y; Li P; He Q; He S; Gong Y; Wang X; Zhou L Prostate Cancer Prostatic Dis; 2020 Mar; 23(1):116-126. PubMed ID: 31383954 [TBL] [Abstract][Full Text] [Related]
2. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748 [TBL] [Abstract][Full Text] [Related]
3. Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer. Gandaglia G; Fossati N; Zaffuto E; Bandini M; Dell'Oglio P; Bravi CA; Fallara G; Pellegrino F; Nocera L; Karakiewicz PI; Tian Z; Freschi M; Montironi R; Montorsi F; Briganti A Eur Urol; 2017 Oct; 72(4):632-640. PubMed ID: 28412062 [TBL] [Abstract][Full Text] [Related]
4. PI-RADS version 2: Preoperative role in the detection of normal-sized pelvic lymph node metastasis in prostate cancer. Park SY; Shin SJ; Jung DC; Cho NH; Choi YD; Rha KH; Hong SJ; Oh YT Eur J Radiol; 2017 Jun; 91():22-28. PubMed ID: 28629566 [TBL] [Abstract][Full Text] [Related]
5. Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool. Gandaglia G; Barletta F; Robesti D; Scuderi S; Rajwa P; Gomez Rivas J; Ibanez L; Soeterik TFW; Bianchi L; Afferi L; Kesch C; Darr C; Guo H; Zhuang J; Zattoni F; Fendler W; Marra G; Stabile A; Amparore D; Huebner NA; Giesen A; Joniau S; Schiavina R; Brunocilla E; Mattei A; Dal Moro F; Sierra JM; Porpiglia F; Picchio M; van den Bergh R; Shariat SF; Montorsi F; Briganti A Eur Urol Oncol; 2023 Dec; 6(6):543-552. PubMed ID: 37270378 [TBL] [Abstract][Full Text] [Related]
6. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies. Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Fossati N; Stabile A; Beauval JB; Malavaud B; Roumiguié M; Robesti D; Dell'Oglio P; Moschini M; Zamboni S; Rakauskas A; De Cobelli F; Porpiglia F; Montorsi F; Briganti A Eur Urol; 2019 Mar; 75(3):506-514. PubMed ID: 30342844 [TBL] [Abstract][Full Text] [Related]
7. Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion. Oderda M; Diamand R; Albisinni S; Calleris G; Carbone A; Falcone M; Fiard G; Gandaglia G; Marquis A; Marra G; Parola C; Pastore A; Peltier A; Ploussard G; Roumeguère T; Sanchez-Salas R; Simone G; Smelzo S; Witt JH; Gontero P BJU Int; 2021 Mar; 127(3):318-325. PubMed ID: 32869940 [TBL] [Abstract][Full Text] [Related]
8. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection. Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120 [TBL] [Abstract][Full Text] [Related]
9. Validation of nomograms predicting lymph node involvement in patients with prostate cancer undergoing extended pelvic lymph node dissection. Hinev AI; Anakievski D; Kolev NH; Hadjiev VI Urol Int; 2014; 92(3):300-5. PubMed ID: 24480972 [TBL] [Abstract][Full Text] [Related]
10. First North American validation and head-to-head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomy. Bandini M; Marchioni M; Pompe RS; Tian Z; Gandaglia G; Fossati N; Abdollah F; Graefen M; Montorsi F; Saad F; Shariat SF; Briganti A; Karakiewicz PI BJU Int; 2018 Apr; 121(4):592-599. PubMed ID: 29124911 [TBL] [Abstract][Full Text] [Related]
11. A novel nomogram predicting lymph node invasion among patients with prostate cancer: The importance of extracapsular extension at multiparametric magnetic resonance imaging. Di Trapani E; Luzzago S; Peveri G; Catellani M; Ferro M; Cordima G; Mistretta FA; Bianchi R; Cozzi G; Alessi S; Matei DV; Bagnardi V; Petralia G; Musi G; De Cobelli O Urol Oncol; 2021 Jul; 39(7):431.e15-431.e22. PubMed ID: 33423938 [TBL] [Abstract][Full Text] [Related]
12. External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection. Gandaglia G; Martini A; Ploussard G; Fossati N; Stabile A; De Visschere P; Borgmann H; Heidegger I; Steinkohl F; Kretschmer A; Marra G; Mathieu R; Surcel C; Tilki D; Tsaur I; Valerio M; Van den Bergh R; Ost P; Gontero P; Montorsi F; Briganti A; Eur Urol; 2020 Aug; 78(2):138-142. PubMed ID: 32268944 [TBL] [Abstract][Full Text] [Related]
13. External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging. Soeterik TFW; Hueting TA; Israel B; van Melick HHE; Dijksman LM; Stomps S; Biesma DH; Koffijberg H; Sedelaar M; Witjes JA; van Basten JA BJU Int; 2021 Aug; 128(2):236-243. PubMed ID: 33630398 [TBL] [Abstract][Full Text] [Related]
14. External Validation of Models Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients. Hueting TA; Cornel EB; Somford DM; Jansen H; van Basten JA; Pleijhuis RG; Korthorst RA; van der Palen JAM; Koffijberg H Eur Urol Oncol; 2018 Oct; 1(5):411-417. PubMed ID: 31158080 [TBL] [Abstract][Full Text] [Related]
15. Prostate Magnetic Resonance Imaging Provides Limited Incremental Value Over the Memorial Sloan Kettering Cancer Center Preradical Prostatectomy Nomogram. Weaver JK; Kim EH; Vetter JM; Shetty A; Grubb RL; Strope SA; Andriole GL Urology; 2018 Mar; 113():119-128. PubMed ID: 29217354 [TBL] [Abstract][Full Text] [Related]
16. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection. Briganti A; Abdollah F; Nini A; Suardi N; Gallina A; Capitanio U; Bianchi M; Tutolo M; Passoni NM; Salonia A; Colombo R; Freschi M; Rigatti P; Montorsi F Eur Urol; 2012 Jun; 61(6):1132-8. PubMed ID: 22099610 [TBL] [Abstract][Full Text] [Related]
17. Preoperative prediction of pelvic lymph nodes metastasis in prostate cancer using an ADC-based radiomics model: comparison with clinical nomograms and PI-RADS assessment. Liu X; Wang X; Zhang Y; Sun Z; Zhang X; Wang X Abdom Radiol (NY); 2022 Sep; 47(9):3327-3337. PubMed ID: 35763053 [TBL] [Abstract][Full Text] [Related]
18. Benefit and harm of lymphadenectomy in intermediate risk prostate cancer: comparison of five nomograms. Lodeta B; Baric H; Hatz D; Jozipovic D; Augustin H BMC Urol; 2023 Nov; 23(1):190. PubMed ID: 37980520 [TBL] [Abstract][Full Text] [Related]
19. Head-to-Head Comparison of Two Nomograms Predicting Probability of Lymph Node Invasion in Prostate Cancer and the Therapeutic Impact of Higher Nomogram Threshold. Venclovas Z; Muilwijk T; Matjosaitis AJ; Jievaltas M; Joniau S; Milonas D J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33801231 [No Abstract] [Full Text] [Related]
20. Development of a novel nomogram incorporating platelet-to-lymphocyte ratio for the prediction of lymph node involvement in prostate carcinoma. Merhe A; Labban M; Hout M; Bustros G; Abou Heidar N; El-Asmar JM; Bulbul M; El Hajj A Urol Oncol; 2020 Dec; 38(12):930.e1-930.e6. PubMed ID: 32736935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]